Tocqueville Asset Management L.P. Intra Cellular Therapies, Inc. Transaction History

Tocqueville Asset Management L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 31, 2019	SELL	$7.47 - $14.03 $210,131 - $394,663	-28,130 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$10.65 - $14.29 $57,776 - $77,523	5,425 Added 23.89%	28,130 $365,000
Q1 2019 Apr 30, 2019	SELL	$10.9 - $14.09 $21,582 - $27,898	-1,980 Reduced 8.02%	22,705 $277,000
Q4 2018 Feb 08, 2019	SELL	$10.36 - $20.96 $3,885 - $7,860	-375 Reduced 1.5%	24,685 $281,000
Q2 2018 Aug 13, 2018	BUY	$17.33 - $23.4 $129,974 - $175,500	7,500 Added 42.71%	25,060 $443,000
Q1 2018 May 14, 2018	SELL	$15.16 - $25.49 $98,540 - $165,685	-6,500 Reduced 27.02%	17,560 $370,000
Q4 2017 Feb 13, 2018	BUY	$14.27 - $16.79 $167,458 - $197,030	11,735 Added 95.21%	24,060 $348,000
Q3 2017 Oct 30, 2017	BUY	$10.77 - $22.1 $132,740 - $272,382	12,325	12,325 $194,000

378

84.1M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.86B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.